文献速递心血管CTMR

血浆ACE2活性预测主动脉瓣狭窄患者死亡率并与严重心肌纤维化相关

Plasma ACE2 Activity Predicts Mortality in Aortic Stenosis and Is Associated With Severe Myocardial Fibrosis.
PubMed 文献 · JACC Cardiovasc Imaging · 2019-10-11

本研究在127例主动脉瓣狭窄患者中测量血浆ACE2活性,发现其与瓣膜钙化及左心室质量指数相关;中位随访5年,血浆ACE2升高是全因死亡的独立预测因子(HR 2.28),且与心肌ACE2基因表达降低及严重心肌纤维化相关。

要点

  • 血浆ACE2活性中位数34.0 pmol/ml/min,高于中位者左室舒张末期容积更大(57 vs 48 ml/m2)。
  • 校正临床、影像和生化参数后,血浆ACE2升高仍独立预测全因死亡(HR 2.28)。
  • 循环ACE2升高与心肌ACE2基因表达降低(0.7倍)及严重心肌纤维化相关。

核心结论

  • 在主动脉瓣狭窄患者中,血浆ACE2升高是心肌结构异常的标志物,也是独立于传统预后标志物的死亡预测因子;心肌ACE2丢失与纤维化增加及循环ACE2升高相关。

研究设计与样本

  • 研究论文;127例主动脉瓣狭窄患者测量血浆ACE2活性,其中部分患者在主动脉瓣置换时采集心肌组织;中位随访5年。

关键影像表现/征象

  • 血浆ACE2活性与瓣膜钙化增加相关(p=0.023)。
  • 血浆ACE2活性与左心室质量指数相关(r=0.34;p<0.001)。
  • 血浆ACE2高于中位者左室舒张末期容积更高(57 ml/m2 vs 48 ml/m2;p=0.021)。
  • 22例有血浆和组织数据的患者中,循环ACE2升高与心肌ACE2基因表达降低相关(0.7倍;p=0.033)。
  • 22例有血浆和组织数据的患者中,循环ACE2升高与严重心肌纤维化相关(p=0.027)。

诊断标准与关键数值

  • 血浆ACE2活性中位数为34.0 pmol/ml/min,以高于中位数定义升高。
  • 血浆ACE2升高预测全因死亡:HR 2.28(95%CI 1.03–5.06;p=0.042),校正临床、影像和生化参数后。
  • 在脑钠肽激活基础上,血浆ACE2升高提供增量预后价值:综合判别改善指数0.08(p<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study investigated the relationship between plasma angiotensin-converting enzyme 2 (ACE2) activity levels and the severity of stenosis and myocardial remodeling in patients with aortic stenosis (AS) and determined if plasma ACE2 levels offered incremental prognostic usefulness to predict all-cause mortality.

BACKGROUND: ACE2 is an integral membrane protein that degrades angiotensin II and has an emerging role as a circulating biomarker of cardiovascular disease.

METHODS: Plasma ACE2 activity was measured in 127 patients with AS; a subgroup had myocardial tissue collected at the time of aortic valve replacement.

RESULTS: The median plasma ACE2 activity was 34.0 pmol/ml/min, and levels correlated with increased valvular calcification (p = 0.023) and the left ventricular (LV) mass index (r = 0.34; p < 0.001). Patients with above-median plasma ACE2 had higher LV end-diastolic volume (57 ml/m2 vs. 48 ml/m2; p = 0.021). Over a median follow-up of 5 years, elevated plasma ACE2 activity was an independent predictor of all-cause mortality after adjustment for relevant clinical, imaging, and biochemical parameters (HR: 2.28; 95% CI: 1.03 to 5.06; p = 0.042), including brain natriuretic peptide activation (integrated discrimination improvement: 0.08; p < 0.001). In 22 patients with plasma and tissue, increased circulating ACE2 was associated with reduced myocardial ACE2 gene expression (0.7-fold; p = 0.033) and severe myocardial fibrosis (p = 0.027).

CONCLUSIONS: In patients with AS, elevated plasma ACE2 was a marker of myocardial structural abnormalities and an independent predictor of mortality with incremental value over traditional prognostic markers. Loss of ACE2 from the myocardium was associated with increased fibrosis and higher circulating ACE2 levels.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Ramchand J, Patel SK, Kearney LG, et al. Plasma ACE2 Activity Predicts Mortality in Aortic Stenosis and Is Associated With Severe Myocardial Fibrosis. JACC Cardiovasc Imaging. 2019. PMID: 31607667. doi:10.1016/j.jcmg.2019.09.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。